(Q35343060)

7 August 2017

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate (English)

1 reference

7 August 2017

Fass RJ

1

1 reference

PubMed ID

2552904

7 August 2017

Prior RB

series ordinal

2

1 reference

PubMed ID

2552904

7 August 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

1 reference

7 August 2017

33

1 reference

7 August 2017

8

1 reference

7 August 2017

1268-1274

1 reference

Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

In vitro susceptibilities of four species of coagulase-negative staphylococci

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172638

Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2552904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2552904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.33.8.1268

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

PubMed ID

2552904